nach oben

20.11.2018 | Original Article

Cultural adaptation and validation of the Turkish CONTILIFE: a quality of life questionnaire for urinary incontinence

verfasst von: Ceren Orhan, Serap Özgül, Emine Baran, Esra Üzelpasacı, Gülbala Nakip, Gamze Nalan Çinar, Mehmet Sinan Beksaç, Türkan Akbayrak

Erschienen in: International Urogynecology Journal

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The objective of the present study was to adapt the CONTILIFE, a quality-of-life questionnaire, into Turkish and to reveal its psychometric properties in women suffering from stress urinary incontinence (SUI).

Methods

Ninety-eight patients with a symptom of SUI participated in the study and filled out the Turkish CONTILIFE. Cronbach’s alpha (α) and intraclass correlation coefficients (ICCs) were evaluated for the internal consistency and test-retest reliability, respectively. Exploratory factor analysis was performed to determine the underlying structure. Criterion validity was analyzed using the correlation coefficients between the total and subscale scores of the CONTILIFE and King’s Health Questionnaire (KHQ), the Incontinence Impact Questionnaire-7 (IIQ-7), and the Urinary Distress Inventory-6 (UDI-6).

Results

Internal consistency was found to be strong to very strong (Cronbach’s α: 0.90–0.96). Test-retest reliability was very strong (ICCs = 0.91–0.98, p < 0.001). Exploratory factor analysis revealed five significant factors, explained by 74% of the total variance. Total scores on the CONTILIFE were significantly correlated with the KHQ subscales (r = −0.43 − −0.81), IIQ-7 (r = −0.89), UDI-6 (r = −0.66), and ISI (r = −0.66); (p < 0.01).

Conclusion

The Turkish CONTILIFE is a valid and reliable tool to determine the influence of SUI on health-related quality of life in Turkish women.

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26. https://doi.org/10.1007/s00192-009-0976-9.CrossRefPubMed

Hannestad YS, Rortveit G, Sandvik H, Hunskaar S, Norwegian EEICN-T. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of incontinence in the county of Nord-Trondelag. J Clin Epidemiol. 2000;53(11):1150–7.CrossRef

Milsom I. The prevalence of urinary incontinence. Acta Obstet Gynecol Scand. 2000;79(12):1056–9.PubMed

Akkus Y, Pinar G. Evaluation of the prevalence, type, severity, and risk factors of urinary incontinence and its impact on quality of life among women in Turkey. Int Urogynecol J. 2016;27(6):887–93. https://doi.org/10.1007/s00192-015-2904-5.CrossRefPubMed

Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health-related quality of life of stress urge and mixed urinary incontinence. BJU Int. 2003;92(7):731–5.CrossRef

Lagro-Janssen TL, Smits AJ, Van Weel C. Women with urinary incontinence: self-perceived worries and general practitioners’ knowledge of problem. Br J Gen Pract. 1990;40(337):331–4.PubMedPubMedCentral

Ghoniem G, Stanford E, Kenton K, Achtari C, Goldberg R, Mascarenhas T, et al. Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(1):5–33. https://doi.org/10.1007/s00192-007-0495-5.CrossRefPubMed

Patrick DL, Martin ML, Bushnell DM, Marquis P, Andrejasich CM, Buesching DP. Cultural adaptation of a quality-of-life measure for urinary incontinence. Eur Urol. 1999;36(5):427–35. https://doi.org/10.1159/000020026.CrossRefPubMed

Oh SJ, Ku JH. Is a generic quality of life instrument helpful for evaluating women with urinary incontinence? Qual Life Res. 2006;15(3):493–501. https://doi.org/10.1007/s11136-005-2487-6.CrossRefPubMed

10.

Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F. European psychometric validation of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Eur Urol. 2003;43(4):391–404.CrossRef

11.

Gotoh M. Quality of life assessment for patients with urinary incontinence. Nagoya J Med Sci. 2007;69(3–4):123–31.PubMed

12.

Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care. I: applications and issues in assessment. BMJ. 1992;305(6861):1074–7.CrossRef

13.

Kaya S, Akbayrak T, Toprak Celenay S, Dolgun A, Ekici G, Beksac S. Reliability and validity of the Turkish King’s health questionnaire in women with urinary incontinence. Int Urogynecol J. 2015;26(12):1853–9. https://doi.org/10.1007/s00192-015-2786-6.CrossRefPubMed

14.

Rogowski A, Bienkowski P, Samochowiec J, Mierzejewski P, Jerzak M, Baranowski W. Reliability and clinical validity of a polish version of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Int Urogynecol J. 2010;21(6):731–6. https://doi.org/10.1007/s00192-009-1095-3.CrossRefPubMed

15.

Ozengin N, Kaya S, Orhan C, Bakar Y, Duran B, Ankarali H, et al. Turkish adaptation of the pelvic organ prolapse symptom score and its validity and reliability. Int Urogynecol J. 2017;28(8):1217–22. https://doi.org/10.1007/s00192-016-3251-x.CrossRefPubMed

16.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186–91.CrossRef

17.

Brubaker L, Lukacz ES, Burgio K, Zimmern P, Norton P, Leng W, et al. Mixed incontinence: comparing definitions in non-surgical patients. Neurourol Urodyn. 2011;30(1):47–51. https://doi.org/10.1002/nau.20922.CrossRefPubMedPubMedCentral

18.

Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health. 1993;47(6):497–9.CrossRef

19.

Sandvik H, Seim A, Vanvik A, Hunskaar S. A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests. Neurourol Urodyn. 2000;19(2):137–45.CrossRef

20.

O’Sullivan R, Karantanis E, Stevermuer TL, Allen W, Moore KH. Definition of mild, moderate and severe incontinence on the 24-hour pad test. BJOG. 2004;111(8):859–62. https://doi.org/10.1111/j.1471-0528.2004.00211.x.CrossRefPubMed

21.

Girod I, McCarthy C, Marrel A, De La Loge C, Marquis P (1999) Development and psychometric validation of a quality of life questionnaire in urinary incontinence. Paper presented at the 6th Annual Conference of ISOQOL, Barcelona, Spain, 3–6 November 1999.

22.

Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104(12):1374–9.CrossRef

23.

Cam C, Sakalli M, Ay P, Cam M, Karateke A. Validation of the short forms of the incontinence impact questionnaire (IIQ-7) and the urogenital distress inventory (UDI-6) in a Turkish population. Neurourol Urodyn. 2007;26(1):129–33. https://doi.org/10.1002/nau.20292.CrossRefPubMed

24.

Minassian VA, Drutz HP, Al-Badr A. Urinary incontinence as a worldwide problem. Int J Gynaecol Obstet. 2003;82(3):327–38.CrossRef

25.

Gasquet I, Tcherny-Lessenot S, Gaudebout P, Bosio Le Goux B, Klein P, Haab F. Influence of the severity of stress urinary incontinence on quality of life, health care seeking, and treatment: a national cross-sectional survey. Eur Urol. 2006;50(4):818–25. https://doi.org/10.1016/j.eururo.2006.03.052.CrossRefPubMed

26.

Phe V, Zimmern P, Chartier-Kastler E. Outcome measures for stress urinary incontinence treatment: can we minimally agree? World J Urol. 2015;33(9):1221–34. https://doi.org/10.1007/s00345-015-1524-5.CrossRefPubMed

27.

van der Vaart CH, de Leeuw JR, Roovers JP, Heintz AP. Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited. Neurourol Urodyn. 2003;22(2):97–104. https://doi.org/10.1002/nau.10038.CrossRefPubMed

28.

Saadoun K, Ringa V, Fritel X, Varnoux N, Zins M, Breart G. Negative impact of urinary incontinence on quality of life, a cross-sectional study among women aged 49-61 years enrolled in the GAZEL cohort. Neurourol Urodyn. 2006;25(7):696–702. https://doi.org/10.1002/nau.20245.CrossRefPubMed

29.

Gjersing L, Caplehorn JR, Clausen T. Cross-cultural adaptation of research instruments: language, setting, time and statistical considerations. BMC Med Res Methodol. 2010;10:13. https://doi.org/10.1186/1471-2288-10-13.CrossRefPubMedPubMedCentral

Titel: Cultural adaptation and validation of the Turkish CONTILIFE: a quality of life questionnaire for urinary incontinence
verfasst von: Ceren Orhan
Serap Özgül
Emine Baran
Esra Üzelpasacı
Gülbala Nakip
Gamze Nalan Çinar
Mehmet Sinan Beksaç
Türkan Akbayrak
Publikationsdatum: 20.11.2018
Verlag: Springer International Publishing
Erschienen in: International Urogynecology Journal
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-018-3823-z

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Cultural adaptation and validation of the Turkish CONTILIFE: a quality of life questionnaire for urinary incontinence

Abstract

Introduction and hypothesis

Methods

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Blutdrucksenkung könnte Uterusmyome verhindern

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Update Gynäkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Introduction and hypothesis

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Blutdrucksenkung könnte Uterusmyome verhindern

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Update Gynäkologie